By contrast, the CSFasynSAA− group had higher serum NfL, a biomarker that predicts increased risk of cognitive decline.30 Interpretation of these results requires consideration for sex and age differences in the compared groups, as well as differences in disease duration at enrolment. This evidence concerns the gene NEFL and Mental deterioration.